Subsequently, we noted that the anti-inflammatory agent TSG-6 halted Ccl2−/−/Cx3cr1−/−/Crb1rd8 (DKO/rd8) retinal degeneration and found that treated retinas expressed less Il17a[9]. Here, IL17A is linked to retinal degeneration.